The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Post-COVID-19 symptoms 6 months after acute infection among hospitalized and non-hospitalized patients
Open accessAbstract
Objectives To assess the prevalence of and factors associated with post-coronavirus disease 2019 (COVID-19) syndrome 6 months after the onset. Methods A bidirectional prospective study. Interviews investigated symptoms potentially associated with COVID-19 6 months after the disease onset of all consecutive adult inpatients and outpatients with COVID-19 attending Udine Hospital (Italy) from March to May 2020. IgG antibodies against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) were also evaluated 6 months after the onset of symptoms, at the time of the interview. Results A total of 599 individuals were included (320 female, 53.4%; mean age 53 years, SD 15.8) and interviewed 187 days (22 SD) after onset. The prevalence of post-COVID-19 syndrome was 40.2% (241/599). The presence of IgG antibodies was significantly associated with the occurrence of post-COVID-19 syndrome (OR 2.56, 95% CI 1.48–4.38, p 0.001) and median SARS-CoV-2 IgG titres were significantly higher in patients with post-COVID-19 syndrome than in patients without symptoms (42.1, IQR 17.1–78.4 vs. 29.1, IQR 12.1–54.2 kAU/L, p 0.004). Female gender (OR 1.55, 95% CI 1.05–2.27), a proportional increase in the number of symptoms at the onset of COVID-19 (OR 1.81, 95% CI 1.59–2.05) and ICU admission OR 3.10, 95% CI 1.18–8.11) were all independent risk factors for post-COVID-19 syndrome. The same predictors also emerged in a subgroup of 231 patients with the serological follow-up available at the time of the interview alongside the proportional increase in anti-SARS-CoV-2 IgG (OR 1.01, 95% CI 1.00–1.02, p 0.04). Discussion Prospective follow-up could be offered to specific subgroups of COVID-10 patients, to identify typical symptoms and persistently high anti-SARS-CoV-2 IgG titres as a means of early detection of post-COVID-19 long-term sequelae.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study
Huang, C., Huang, L., Wang, Y., Li, X., Ren, L., Gu, X., Kang, L., Guo, L., Liu, M., Zhou, X., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(20)32656-8 · Cited by 4,084
RetractedPulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19
Ackermann, M., Verleden, S. E., Kuehnel, M., Haverich, A., Welte, T., Laenger, F., Vanstapel, A., Werlein, C., Stark, H., Tzankov, A., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2015432 · Cited by 5,613
Persistent Symptoms in Patients After Acute COVID-19
Carfì, A., Bernabei, R., Landi, F., & for the Gemelli Against COVID-19 Post-Acute Care Study Group (2020) · JAMA · doi:10.1001/jama.2020.12603 · Cited by 4,561 · cited 5×
“As previously reported [2,7], the presence of post-COVID-19 symptoms was significantly associated with the number of symptoms at onset and with the grade of disease requiring an ICU admission; however, as documented [14,15], our findings indicate that COVID-19 can also cause prolonged illness among individuals with mi…”
BackgroundResultInfluentialCharacterizing long COVID in an international cohort: 7 months of symptoms and their impact
Davis, H. E., Assaf, G. S., McCorkell, L., Wei, H., Low, R. J., Re'em, Y., Redfield, S., Austin, J. P., & Akrami, A. (2021) · eClinicalMedicine · doi:10.1016/j.eclinm.2021.101019 · Cited by 2,881
Needham, D. M., Davidson, J., Cohen, H., Hopkins, R. O., Weinert, C., Wunsch, H., Zawistowski, C., Bemis-Dougherty, A., Berney, S. C., Bienvenu, O. J., et al. (2012) · Critical Care Medicine · doi:10.1097/ccm.0b013e318232da75 · Cited by 2,639
Rossi, R., Socci, V., Talevi, D., Mensi, S., Niolu, C., Pacitti, F., Di Marco, A., Rossi, A., Siracusano, A., & Di Lorenzo, G. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00790 · Cited by 1,448
Halpin, S. J., McIvor, C., Whyatt, G., Adams, A., Harvey, O., McLean, L., Walshaw, C., Kemp, S., Corrado, J., Singh, R., et al. (2021) · Journal of Medical Virology · doi:10.1002/jmv.26368 · Cited by 1,402
Tenforde, M. W., Kim, S. S., Lindsell, C. J., Billig Rose, E., Shapiro, N. I., Files, D. C., Gibbs, K. W., Erickson, H. L., Steingrub, J. S., Smithline, H. A., et al. (2020) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6930e1 · Cited by 1,319
Impact of sex and gender on COVID-19 outcomes in Europe
Gebhard, C., Regitz-Zagrosek, V., Neuhauser, H. K., Morgan, R., & Klein, S. L. (2020) · Biology of Sex Differences · doi:10.1186/s13293-020-00304-9 · Cited by 1,306
COVID-19 rapid guideline: managing the long-term effects of COVID-19
Excellence, C. (2020) · Cited by 1,074
Mandal, S., Barnett, J., Brill, S. E., Brown, J. S., Denneny, E. K., Hare, S. S., Heightman, M., Hillman, T. E., Jacob, J., Jarvis, H. C., et al. (2021) · Thorax · doi:10.1136/thoraxjnl-2020-215818 · Cited by 864 · cited 2×
“Fatigue and dyspnoea have been reported among SARS and MERS patients, and are currently being described in COVID-19 survivors, mainly after hospitalization [3,7,17,18].”
Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome?
Goërtz, Y. M. J., Van Herck, M., Delbressine, J. M., Vaes, A. W., Meys, R., Machado, F. V. C., Houben-Wilke, S., Burtin, C., Posthuma, R., Franssen, F. M. E., et al. (2020) · ERJ Open Research · doi:10.1183/23120541.00542-2020 · Cited by 847
COVID-19–Associated Multisystem Inflammatory Syndrome in Children — United States, March–July 2020
Godfred-Cato, S., Bryant, B., Leung, J., Oster, M. E., Conklin, L., Abrams, J., Roguski, K., Wallace, B., Prezzato, E., Koumans, E. H., et al. (2020) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6932e2 · Cited by 769
Follow-up of adults with noncritical COVID-19 two months after symptom onset
Carvalho-Schneider, C., Laurent, E., Lemaignen, A., Beaufils, E., Bourbao-Tournois, C., Laribi, S., Flament, T., Ferreira-Maldent, N., Bruyère, F., Stefic, K., et al. (2021) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2020.09.052 · Cited by 764
Long-term Health Consequences of COVID-19
del Rio, C., Collins, L. F., & Malani, P. (2020) · JAMA · doi:10.1001/jama.2020.19719 · Cited by 711
Immunity and immunopathology to viruses: what decides the outcome?
Rouse, B. T., & Sehrawat, S. (2010) · Nature Reviews Immunology · doi:10.1038/nri2802 · Cited by 619
Ahmed, H., Patel, K., Greenwood, D., Halpin, S., Lewthwaite, P., Salawu, A., Eyre, L., Breen, A., O’Connor, R., Jones, A., et al. (2020) · Journal of Rehabilitation Medicine · doi:10.2340/16501977-2694 · Cited by 596
Characterizing Long COVID in an International Cohort: 7 Months of Symptoms and Their Impact
Davis, H. E., Assaf, G. S., McCorkell, L., Wei, H., Low, R. J., Re’em, Y., Redfield, S., Austin, J. P., & Akrami, A. (2020) · medRxiv · doi:10.1101/2020.12.24.20248802 · Cited by 387
Persistence of symptoms and quality of life at 35 days after hospitalization for COVID-19 infection
Jacobs, L. G., Gourna Paleoudis, E., Lesky-Di Bari, D., Nyirenda, T., Friedman, T., Gupta, A., Rasouli, L., Zetkulic, M., Balani, B., Ogedegbe, C., et al. (2020) · PLOS ONE · doi:10.1371/journal.pone.0243882 · Cited by 321
New understanding of the damage of SARS-CoV-2 infection outside the respiratory system
Zhang, Y., Geng, X., Tan, Y., Li, Q., Xu, C., Xu, J., Hao, L., Zeng, Z., Luo, X., Liu, F., et al. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110195 · Cited by 319
Profile of RT-PCR for SARS-CoV-2: A Preliminary Study From 56 COVID-19 Patients
Xiao, A. T., Tong, Y. X., & Zhang, S. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa460 · Cited by 232
A formal analysis of cytokine networks in chronic fatigue syndrome
Broderick, G., Fuite, J., Kreitz, A., Vernon, S. D., Klimas, N., & Fletcher, M. A. (2010) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2010.04.012 · Cited by 202
Postacute COVID-19: An Overview and Approach to Classification
Amenta, E. M., Spallone, A., Rodriguez-Barradas, M. C., El Sahly, H. M., Atmar, R. L., & Kulkarni, P. A. (2020) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaa509 · Cited by 191
Post–COVID-19 chronic symptoms: a postinfectious entity?
Davido, B., Seang, S., Tubiana, R., & de Truchis, P. (2020) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2020.07.028 · Cited by 158
Wijeratne, T., & Crewther, S. G. (2020) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2020.117179 · Cited by 155
Rheumatic manifestations of COVID-19: a systematic review and meta-analysis
Ciaffi, J., Melicòni, R., Ruscitti, P., Berardicurti, O., Giacomelli, R., & Ursini, F. (2020) · BMC Rheumatology · doi:10.1186/s41927-020-00165-0 · Cited by 118
Taking pandemic sequelae seriously: from the Russian influenza to COVID-19 long-haulers
Honigsbaum, M., & Krishnan, L. (2020) · The Lancet · doi:10.1016/s0140-6736(20)32134-6 · Cited by 117
Diagnostic performances and thresholds: The key to harmonization in serological SARS-CoV-2 assays?
Plebani, M., Padoan, A., Negrini, D., Carpinteri, B., & Sciacovelli, L. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.05.050 · Cited by 101
Community-acquired Respiratory Viruses Are a Risk Factor for Chronic Lung Allograft Dysfunction
Peghin, M., Arcos, I. L., Hirsch, H. H., Codina, G., Monforte, V., Bravo, C., Berastegui, C., Jaúregui, A., Laura, R. V., Cabral, E., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy1047 · Cited by 81
Self-citationPatient-Reported Outcome Assessments as Endpoints in Studies in Infectious Diseases
Powers, J. H., Howard, K. A., Saretsky, T. L., Clifford, S., Hoffmann, S., Llorens, L., & Talbot, G. H. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw317 · Cited by 44
Bardel, A., Wallander, M.-A. A., Wallman, T., Rosengren, A., Johansson, S., Eriksson, H., & Svärdsudd, K. (2019) · PLoS ONE · doi:10.1371/journal.pone.0211532 · Cited by 37
Patient-reported outcomes: central to the management of COVID-19
Aiyegbusi, O. L., & Calvert, M. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31724-4 · Cited by 33
Cited by
Fatigue and cognitive impairment in Post-COVID-19 Syndrome: a systematic review and meta-analysis
Ceban, F., Ling, S., Lui, L. M. W., Lee, Y., Gill, H., Teopiz, K. M., Rodrigues, N. B., Subramaniapillai, M., Di Vincenzo, J. D., Cao, B., et al. (2022) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2021.12.020 · Cited by 1,554
Chen, C., Haupert, S. R., Zimmermann, L., Shi, X., Fritsche, L. G., & Mukherjee, B. (2022) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiac136 · Cited by 1,366
Collaborators, G. B. O. D. L. C., Wulf Hanson, S., Abbafati, C., Aerts, J. G., Al-Aly, Z., Ashbaugh, C., Ballouz, T., Blyuss, O., Bobkova, P., Bonsel, G., et al. (2022) · JAMA · doi:10.1001/jama.2022.18931 · Cited by 970
Risk Factors Associated With Post−COVID-19 Condition: A Systematic Review and Meta-analysis
Tsampasian, V., Elghazaly, H., Chattopadhyay, R., Debski, M., Naing, T. K. P., Garg, P., Clark, A., Ntatsaki, E., & Vassiliou, V. S. (2023) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2023.0750 · Cited by 799
Unexplained post-acute infection syndromes
Choutka, J., Jansari, V., Hornig, M., & Iwasaki, A. (2022) · Nature Medicine · doi:10.1038/s41591-022-01810-6 · Cited by 604
Metadata
- Authors
- Peghin, M., Palese, A., Venturini, M., De Martino, M., Gerussi, V., Graziano, E., Bontempo, G., Marrella, F., Tommasini, A., Fabris, M., Curcio, F., Isola, M., & Tascini, C.
- Venue
- Clinical Microbiology and Infection
- Publisher
- Elsevier BV
- Published
- 2021-10
- Volume
- 27
- Issue
- 10
- Pages
- 1507-1513
- ISSN
- 1198-743X (ISSN-L)
- OpenAlex
- W3168298404
- Cited by
- 305
- References
- 32
- FWCI
- 26.38
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.